Art Mandell - Jun 11, 2024 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Brian Leaf, Attorney-in-Fact
Stock symbol
MXCT
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
4
Date filed
6/13/2024, 05:41 PM
Previous filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Award $0 +21.4K +5.71% $0.00 396K Jun 11, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Award $0 +40.7K $0.00 40.7K Jun 11, 2024 Common Stock 40.7K $4.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date.